Main navigation
Select a type...
Corrigendum—Notice of Reassessment of Registered Trade Name Products (Notice No. MPI ACVM 42)
In the notice with the above title, published in the New Zealand Gazette, 16 October 2024, Notice No. 2024-go5315 replace:
Registration Number:
Trade Name:
Active ingredient(s) and its concentration(s):
Formulation type:
Registrant & Registrant Address:
A06894
Antirobe Capsules 75mg
Clindamycin hydrochloride 75mg
Caspules
Zoetis New Zealand Limited, Level 4, 8 Mahuhu Crescent, Auckland Central, Auckland 1010
A06895
Antirobe Capsules 25mg
Clindamycin hydrochloride 25mg
Capsules
A08150
Antirobe Capsules 150mg
Clindamycin hydrochloride 150mg
A11675
Clindene 150 Tablets
Tablets
Dechra Veterinary Products NZ Limited, 198A Kapiti Road, Paraparaumu 5032
A11978
Clindene 75 Tablets
A11249
Clindacure
Clindamycin 25mg
Oral Solution
Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co. Galway, Ireland
With:
A006894
Antirobe Antibiotic Capsules 75mg
A006895
Antirobe Antibiotic Capsules 25mg
A008150
Antirobe Antibiotic Capsules 150mg
A011675
A011798
A011249
Chanelle Pharmaceuticals Manufacturing Ltd., Dublin Road, Loughrea, Co. Galway, Ireland
Dated at Wellington this 10th day of January 2025.
SHALEEN NARAYAN, Manager Approvals, Ministry for Primary Industries (acting under delegated authority).